Insights from Leading CNS Players
Health Advances
APRIL 24, 2023
This is the fourth and final installment of our ongoing 2022 CNS year in review. See below for our the other blogs in the series: CNS Year in Review: Introduction and Large CNS Diseases CNS Year in Review: Going Digital CNS Year in Review: Novel Modalities Johnson and Johnson (Janssen), Roche, Biogen, Novartis and AbbVie are the leading biopharma players in the CNS space, with collective CNS sales in excess of $30B and active pipelines spanning neurodegeneration, psychiatry, and neurodevelopment
52 52
Let's personalize your content